Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - Priority Announcement: Hepatology

University of Calgary

$45,000.00

Visualizing and killing metastasis in liver

EF 2011-12

Résumé
Many different tumors metastasize to the liver. For example, following colon cancer surgery, it is thought that cells either already in the circulation or those that mobilize from the tumor into the circulation lodge in the liver. The immune system does not recognize these cells as foreign. However, if we could put a bulls-eye on these tumor cells so that the immune system would recognize them, then we would have a way of getting rid of them. We propose to make antibodies that will work as bulls eyes and have immune cells destroy the tumor cells. As one example, the best killing machine of bacteria in the body is the neutrophil, a type of white blood cell. We propose to convince the neutrophils that tumor cells are just like bacteria and need to be killed. We will help tissue-specific immune cells in the liver called Kupffer cells recognize tumors as foreign and kill them. We will also study whether interaction between specific and non-specific immune cell types lead to effective tumor eradication. Understanding how the body works is critical to designing effective drugs. Being able to image and see how tumor cells are killed gives us insight into which cells are important for the killing. Once we know which cells are important we can then help them by activating them to help kill the tumors. Being able to identify which cells are important may impact not just on metastases to the liver, but to primary tumors as well as to metastases in other organs. Drugs are available so what we want to do is determine which are the most effective. Although I have been an immunologist studying infections using imaging expertise, recently we generated sufficient data to get funded by the Alberta Cancer Board to start studying tumor cells. As many as one million colorectal cancer patients will develop metastatic tumors. Preventing this will benefit Albertans, Canadians and beyond.
Programme
Fellowship - Priority Announcement: Hepatology
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
243252
Name
Sokke Umeshappa Channakeshava
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
The Canadian Association for the Study of Liver
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Visualizing and killing metastasis in liver
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement: Hepatology
Keyworddelim
Adoptive Transfer; Gene-Knock Out Mice; Immune Cells (Nk; Immunomodulators; Liver Metastasis; Liver Multichannel Fluore Spinning Disk Intravital Microscop; Neutrophil Extracellular Traps; Neutrophils); Nkt; Opsonizing Antibodies (Iga And Igg); T And Dendritic Cells; Tumor And Immune Cell Interaction Visualization; Tumor Challenge Studies
Abstract
Many different tumors metastasize to the liver. For example, following colon cancer surgery, it is thought that cells either already in the circulation or those that mobilize from the tumor into the circulation lodge in the liver. The immune system does not recognize these cells as foreign. However, if we could put a bulls-eye on these tumor cells so that the immune system would recognize them, then we would have a way of getting rid of them. We propose to make antibodies that will work as bulls eyes and have immune cells destroy the tumor cells. As one example, the best killing machine of bacteria in the body is the neutrophil, a type of white blood cell. We propose to convince the neutrophils that tumor cells are just like bacteria and need to be killed. We will help tissue-specific immune cells in the liver called Kupffer cells recognize tumors as foreign and kill them. We will also study whether interaction between specific and non-specific immune cell types lead to effective tumor eradication. Understanding how the body works is critical to designing effective drugs. Being able to image and see how tumor cells are killed gives us insight into which cells are important for the killing. Once we know which cells are important we can then help them by activating them to help kill the tumors. Being able to identify which cells are important may impact not just on metastases to the liver, but to primary tumors as well as to metastases in other organs. Drugs are available so what we want to do is determine which are the most effective. Although I have been an immunologist studying infections using imaging expertise, recently we generated sufficient data to get funded by the Alberta Cancer Board to start studying tumor cells. As many as one million colorectal cancer patients will develop metastatic tumors. Preventing this will benefit Albertans, Canadians and beyond.
Competitiondate
201110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Sokke Umeshappa, Channakeshava
Approvedterm
2 ans 0 mois
Cihrcontribution2
Patient Oriented Research~ $45,000~ $0~